FFW
PAVM icon

Fusion Family Wealth’s PAVmed PAVM Stock Holding History

Fusion Family Wealth’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-124
Closed -$251K – 277
2017
Q2 		$251K Buy
+124
New +$257K 0.09% 62

Other funds holding PAVM

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fusion Family Wealth's PAVM Position: Q3 2017 in Review

Fusion Family Wealth sold out of PAVmed (PAVM) in Q3 2017, closing a stake of 124 shares — an estimated $251K sold.

Fusion Family Wealth first reported a position in PAVM in Q2 2017 and held it in 1 quarter. The position peaked at $251K in Q2 2017. 7 funds tracked by Wall St. Rank hold PAVM as of Q3 2017.

  • Fusion Family Wealth reported no remaining PAVmed position as of Q3 2017 after selling out during the quarter.
  • Fusion Family Wealth sold 124 PAVmed shares in Q3 2017, an estimated $251K.
  • Fusion Family Wealth first reported a position in PAVmed in Q2 2017 and held it in 1 quarter.
  • Fusion Family Wealth's PAVmed position peaked at $251K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held PAVmed as of Q3 2017.

Based on Fusion Family Wealth's 13F filing for Q3 2017, filed 30 Oct 2017.